Literature DB >> 8598504

Current use of thiazide diuretics and prevention of femur fractures.

R M Herings1, B H Stricker, A de Boer, A Bakker, F Sturmans, A Stergachis.   

Abstract

A case control study of a defined population from The Netherlands was performed to evaluate the risk of femur fractures associated with the use of thiazide diuretics. Included were 386 patients hospitalized for femur fractures between 1986 and 1990 who were residents and 45 years of age and older. Per case, one age-, sex-, pharmacy-, and general practitioner-matched control was chosen from the general population. Drug use was ascertained from computerized pharmacy records. The adjusted odds ratio of current use of thiazide diuretics was 0.5 (95% confidence interval, 0.3-0.9). The protective effect of thiazide diuretics was greatest for use of 1 year or longer at relatively high doses of thiazides (odds ratio, 0.3; 95% confidence interval, 0.1-0.9). We also found that patients who discontinued thiazide use longer than 2 months were not protected against femur fractures. These results support the hypothesis that use of thiazide diuretics protects against femur fractures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598504     DOI: 10.1016/0895-4356(95)00552-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  22 in total

1.  Psychotropic medications and the risk of fracture: a meta-analysis.

Authors:  Bahi Takkouche; Agustín Montes-Martínez; Sudeep S Gill; Mahyar Etminan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

3.  Relationship between use of antidepressants and risk of fractures: a meta-analysis.

Authors:  V Rabenda; D Nicolet; C Beaudart; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-05-26       Impact factor: 4.507

4.  The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women.

Authors:  M J Bolland; R W Ames; A M Horne; B J Orr-Walker; G D Gamble; I R Reid
Journal:  Osteoporos Int       Date:  2006-11-21       Impact factor: 4.507

5.  Use of organic nitrates and the risk of hip fracture: a population-based case-control study.

Authors:  Sander Pouwels; Arief Lalmohamed; Tjeerd van Staa; Cyrus Cooper; Patrick Souverein; Hubertus G Leufkens; Lars Rejnmark; Anthonius de Boer; Peter Vestergaard; Frank de Vries
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

6.  Use of anti-depressants and the risk of fracture of the hip or femur.

Authors:  M W M van den Brand; S Pouwels; M M Samson; T P van Staa; B Thio; C Cooper; H G M Leufkens; A C G Egberts; H J J Verhaar; F de Vries
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

Review 7.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

8.  Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

9.  Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents.

Authors:  Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Catherijne A J Knibbe; Anthonius de Boer; Aukje K Mantel-Teeuwisse
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

10.  Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.

Authors:  S Pouwels; T P van Staa; A C G Egberts; H G M Leufkens; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2009-01-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.